Global Molecular Imaging Agents Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratification, and follow-up of patients with neurological diseases. Imaging agents are the substances designed to improve the imaging output of specific organs, physiological functions, tissues and diseases. Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study.
Based on types, the global molecular imaging agents market is segmented into small molecules, peptides, engineered protein fragments, aptamers, nanoparticles and others. Amongst all, peptides have emerged as a very important type of molecular imaging agents. Based on application, the global molecular imaging agents market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disoeder. Similarly, based on end user, the market is segmented into, hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. Diagnostic & imaging centers are expected to hold maximum share in the market due to the ease of availability of medication.

Market Analysis and Insights: Global Molecular Imaging Agents Market
In 2020, the global Molecular Imaging Agents market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% between 2021 and 2027
Global Molecular Imaging Agents Scope and Market Size
The global Molecular Imaging Agents market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Imaging Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.

Segment by Type
Small Molecules
Peptides
Engineered Protein Fragments
Aptamers
Nanoparticles
Others

Segment by Application
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Others

By Company
General Electric
Bracco Diagnostic
Eisai
Guerbet

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE